InTouch taps ex-Angiodynamics CEO DeVivo as new chief exec

InTouch Health said last week it tapped ex-AngioDynamics (NSDQ:ANGO) CEO Joseph DeVivo to serve as its new chief executive officer, replacing Yulun Wang who has served as board chair and CEO since the company’s founding in 2002.

DeVivo operated as CEO and director at Angiodynamics from 2011 to 2016, and also held positions with Smith & Nephew (NYSE:SNN), the company said.

“I am honored to join InTouch Health at this very exciting time. I’m thrilled to be part of such an innovative, growing business that delivers market leading telehealth technologies and services to health systems around the world. InTouch Health is at a pivotal stage and is ready to accelerate growth and scale. I look forward to leading the company’s expansion of its enterprise-wide, cloud-based telemedicine platform, while adding specialist physician led services and new clinical applications to its offering,” DeVivo said in a press release.

Wang will stay on with the company as board chair, InTouch Health said.

“I have known Joe DeVivo for more than 20 years both professionally and personally, and I’m delighted to have him lead InTouch Health as our new CEO. He brings the right kind of leadership and experience to help our customers and company achieve increasing success as telehealth expands on a global scale,” Wang said in prepared remarks.
Read more

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW